As companies aim to cut costs and reel in spending amid uncertain macroeconomic conditions, Form Bio thinks it is actually the perfect time to launch its platform. The software company was developed ...

DALLAS--(BUSINESS WIRE)--Form Bio, the breakthrough AI-powered drug discovery platform, announced today its notable achievements and product advancements for the first half of 2023. The company’s ...

If you were tasked with resurrecting an extinct animal, where would you even begin? Colossal Biosciences, a synthetic biology company founded in 2021 by a Harvard geneticist George Church and ...

When George Church, PhD, and co-founders established Colossal Biosciences, they envisioned applying their advancements in CRISPR gene editing to the loss of biodiversity, species preservation, and ...

"Form Bio is at the forefront of a revolution in how new genetic medicines are discovered and developed," said Dr. Michelle Chen, CEO of Form Bio. "The opportunity to lead this next chapter, scaling ...

SAN FRANCISCO, June 27, 2024 (Newswire.com) - Form Bio, the provider of advanced computational life sciences technology and PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate ...

Combination of PacBio's HiFi Sequencing Capabilities and Form Bio's Computational Platform and Solutions Helps Biopharma and Academic Researchers Innovate and Accelerates Gene Therapy Product ...

Form Bio, the breakthrough computational life sciences platform, announced that it has been selected to help organizations adopt Google Cloud's Multiomics Suite, accelerating the research of life ...

DALLAS, February 28, 2024 (Newswire.com) - Form Bio, the breakthrough computational life sciences solutions provider, and Ginkgo Bioworks, which is building the leading platform for cell programming ...

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. BURLINGTON, Mass., May 13, 2025 /PRNewswire/ -- Azenta, Inc. ...